Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 5
2005 17
2006 11
2007 15
2008 19
2009 10
2010 20
2011 16
2012 16
2013 14
2014 22
2015 23
2016 27
2017 28
2018 38
2019 34
2020 48
2021 48
2022 29
2023 25
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: kimura s. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
Evolution of CML treatment.
Kimura S. Kimura S. Int J Hematol. 2021 May;113(5):622-623. doi: 10.1007/s12185-021-03128-4. Epub 2021 Mar 15. Int J Hematol. 2021. PMID: 33721192 No abstract available.
Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma.
Ureshino H, Kamachi K, Kimura S. Ureshino H, et al. Among authors: kimura s. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):326-331. doi: 10.1016/j.clml.2019.03.004. Epub 2019 Mar 23. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30981611 Review.
Ever-advancing chronic myeloid leukemia treatment.
Kimura S, Ando T, Kojima K. Kimura S, et al. Int J Clin Oncol. 2014 Feb;19(1):3-9. doi: 10.1007/s10147-013-0641-7. Epub 2013 Nov 22. Int J Clin Oncol. 2014. PMID: 24258348 Review.
Role of cancer immunology in chronic myelogenous leukemia.
Ureshino H, Shindo T, Kimura S. Ureshino H, et al. Among authors: kimura s. Leuk Res. 2020 Jan;88:106273. doi: 10.1016/j.leukres.2019.106273. Epub 2019 Nov 18. Leuk Res. 2020. PMID: 31765938 Review.
Pleural lymphoma combined with pleural sarcoidosis.
Tashiro H, Takahashi K, Komiya N, Miyahara N, Hiratsuka M, Okamoto S, Kido S, Kimura S, Sueoka-Aragane N. Tashiro H, et al. Among authors: kimura s. Respir Investig. 2023 Nov;61(6):698-701. doi: 10.1016/j.resinv.2023.07.010. Epub 2023 Sep 15. Respir Investig. 2023. PMID: 37708635
403 results